| Secondary |
| Product Used For Unknown Indication |
61.6% |
| Pain |
6.8% |
| Depression |
3.8% |
| Diarrhoea |
3.0% |
| Pyrexia |
2.6% |
| Suicide Attempt |
2.2% |
| Abdominal Pain |
2.1% |
| Hypertension |
2.1% |
| Lung Neoplasm Malignant |
2.1% |
| Constipation |
1.8% |
| Diabetes Mellitus |
1.8% |
| Convulsion |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Back Pain |
1.3% |
| Cardiac Disorder |
1.0% |
| Chest Pain |
1.0% |
| Crohn's Disease |
1.0% |
| Inflammation |
1.0% |
| Anxiety |
0.8% |
| Blood Cholesterol Increased |
0.8% |
|
| Abdominal Pain |
13.9% |
| Toxicity To Various Agents |
11.1% |
| Suicide Attempt |
6.9% |
| Weight Decreased |
6.9% |
| Weight Increased |
6.9% |
| Cardio-respiratory Arrest |
5.6% |
| Sopor |
5.6% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Death |
4.2% |
| Product Quality Issue |
4.2% |
| Tourette's Disorder |
4.2% |
| Abdominal Distension |
2.8% |
| Abscess Intestinal |
2.8% |
| Adverse Drug Reaction |
2.8% |
| Dizziness |
2.8% |
| Gastric Ulcer |
2.8% |
| Hepatic Function Abnormal |
2.8% |
| Poisoning |
2.8% |
| Pulmonary Embolism |
2.8% |
| Renal Failure |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.0% |
| Pain |
17.8% |
| Hypertension |
5.4% |
| Schizophrenia |
5.4% |
| Constipation |
4.0% |
| Diabetes Mellitus |
3.7% |
| Cardiac Disorder |
3.1% |
| Depression |
2.6% |
| Rheumatoid Arthritis |
2.4% |
| Schizoaffective Disorder |
2.4% |
| Prophylaxis |
2.2% |
| Anxiety |
2.1% |
| Crohn's Disease |
1.9% |
| Fibromyalgia |
1.8% |
| Multiple Allergies |
1.8% |
| Medical Diet |
1.7% |
| Withdrawal Syndrome |
1.7% |
| Headache |
1.4% |
| Hyperlipidaemia |
1.4% |
| Diffuse Large B-cell Lymphoma |
1.3% |
|
| Wrong Technique In Drug Usage Process |
9.9% |
| Cheilitis |
7.9% |
| Weight Increased |
7.9% |
| Withdrawal Syndrome |
6.9% |
| Vomiting |
5.9% |
| Adverse Drug Reaction |
5.0% |
| Blood Glucose Increased |
5.0% |
| Dizziness |
5.0% |
| Hyperhidrosis |
5.0% |
| Malaise |
5.0% |
| Overdose |
5.0% |
| Underdose |
5.0% |
| Inappropriate Schedule Of Drug Administration |
4.0% |
| Syncope |
4.0% |
| Tremor |
4.0% |
| Cystitis |
3.0% |
| Depression |
3.0% |
| Feeling Abnormal |
3.0% |
| Oesophageal Varices Haemorrhage |
3.0% |
| Product Quality Issue |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
58.3% |
| Diarrhoea |
25.0% |
| Abdominal Pain |
8.3% |
| Sarcoma Uterus |
8.3% |
|
| Epilepsy |
25.0% |
| Megacolon |
25.0% |
| Nausea |
25.0% |
| Pleural Effusion |
25.0% |
|
